These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16535923)

  • 1. [Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?].
    Miele L; Gabrieli ML; Forgione A; Vero V; Gallo A; Capristo E; Gasbarrini G; Grieco A
    Recenti Prog Med; 2006 Jan; 97(1):1-5. PubMed ID: 16535923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J; Torok N
    Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatty liver and global cardiometabolic risk].
    Szollár L
    Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension.
    Kemse NG; Kale AA; Joshi SR
    PLoS One; 2014; 9(11):e111902. PubMed ID: 25405347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome.
    Buettner R; Bettermann I; Hechtl C; Gäbele E; Hellerbrand C; Schölmerich J; Bollheimer LC
    Horm Metab Res; 2010 Oct; 42(11):769-74. PubMed ID: 20803414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin supplements.
    Med Lett Drugs Ther; 1998 Jul; 40(1032):75-7. PubMed ID: 9706283
    [No Abstract]   [Full Text] [Related]  

  • 7. [NASH -- nonalcoholic steatohepatitis].
    Blechacz B; Stremmel W
    Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.
    Patrick L
    Altern Med Rev; 2002 Aug; 7(4):276-91. PubMed ID: 12197781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes.
    Bouderba S; Sanchez-Martin C; Villanueva GR; Detaille D; Koceïr EA
    J Diabetes; 2014 Mar; 6(2):184-92. PubMed ID: 23953934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Steatohepatitis and metabolic and nutritional abnormalities].
    Deugnier Y; Lainé F
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B9-12. PubMed ID: 12843931
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Crabb DW
    Am J Gastroenterol; 2004 Aug; 99(8):1497-502. PubMed ID: 15307867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy for non-alcoholic steatohepatitis].
    Tomita K; Hibi T
    Nihon Rinsho; 2006 Jun; 64(6):1146-51. PubMed ID: 16768123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
    Dumas ME; Kinross J; Nicholson JK
    Gastroenterology; 2014 Jan; 146(1):46-62. PubMed ID: 24211299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.
    Vignozzi L; Filippi S; Comeglio P; Cellai I; Sarchielli E; Morelli A; Rastrelli G; Maneschi E; Galli A; Vannelli GB; Saad F; Mannucci E; Adorini L; Maggi M
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):143-54. PubMed ID: 24486698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
    Shi HB; Fu JF; Liang L; Wang CL; Zhu JF; Zhou F; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Group B vitamins as new variables related to the cardiovascular risk].
    Granieri M; Bellisarii FI; De Caterina R
    Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease.
    Sanyal AJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):46-53. PubMed ID: 16265100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.